Swiss pharmaceutical behemoth Roche Holdings (OTCMKTS ADR: RHHBF) couldn't wait until Monday to announce its biggest deal in five years.
Sunday, the healthcare giant said it is buying California-based biotech company InterMune Inc. (Nasdaq: ITMN) in an $8.3 billion all-cash transaction.
Here’s what’s behind the deal, and where ITMN stock is headed on the news…
Swiss pharmaceutical behemoth Roche Holdings (OTCMKTS ADR: RHHBF) couldn't wait until Monday to announce its biggest deal in five years.
Sunday, the healthcare giant said it is buying California-based biotech company InterMune Inc. (Nasdaq: ITMN) in an $8.3 billion all-cash transaction.
Here’s what’s behind the deal, and where ITMN stock is headed on the news…
